Showing results (831-840 of 871) with videos related to

Sort By:
Pageof 88
PLOS Global Public Health|September 5, 2023
Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling studyMaitreyi Sahu, Cara J Bayer, D Allen Roberts, et al.
Plos One|May 5, 2022
Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trialNadine Tschumi, Malebanye Lerotholi, Mathebe Kopo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2023
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series AnalysisMatthew A Spinelli, Katerina A Christopoulos, Carlos V Moreira, et al.
Clinical Pharmacokinetics|March 29, 2025
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026sJennifer A Hughes, Mauricio Pinilla, Kristina M Brooks, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infantsPatricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
Neurology|September 13, 2022
Characteristics and Gender Differences of Headache in the Veterans Health Administration: A National Cohort Study, Fiscal Year 2008-2019Jason Jonathon Sico, Elizabeth K Seng, Kaicheng Wang, et al.
JAMA|March 14, 2022
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialAnil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026sMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Cumulative TB disease burden following sputum Xpert Ultra 'Trace' results in clinical settings: Results from a multi-site observational clinical studyRonit R Dalmat, Caitlin Visek, Elvira Budiawan, et al.
Eclinicalmedicine|October 4, 2021
Does tuberculosis screening improve individual outcomes? A systematic reviewL Telisinghe, M Ruperez, M Amofa-Sekyi, et al.
Pageof 88